XML 38 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Summary of Stock Option Activity

A summary of stock option activity under the 2020 Plan during the three months ended March 31, 2024 is as follows (in thousands except share and per share data):

 

 

 

Number of
Options
Outstanding

 

 

Weighted
Average
Strike
Price per
Option

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2023

 

 

8,113,164

 

 

$

28.25

 

 

 

7.69

 

 

$

49,622

 

Granted

 

 

2,192,471

 

 

 

42.99

 

 

 

 

 

 

 

Exercised

 

 

(281,021

)

 

 

14.00

 

 

 

 

 

 

 

Forfeited

 

 

(147,900

)

 

 

30.68

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

9,876,714

 

 

$

31.90

 

 

 

8.00

 

 

$

109,297

 

Exercisable at March 31, 2024

 

 

5,093,242

 

 

$

26.90

 

 

 

6.87

 

 

$

84,120

 

Summary of Equity-Based Compensation Expense

The following table outlines our equity-based compensation expense for stock options for the three months ended March 31, 2024 and 2023:

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

5,040

 

 

$

4,184

 

General and administrative

 

 

5,322

 

 

 

4,349

 

Total equity-based compensation

 

$

10,362

 

 

$

8,533

 

Summary of Weighted-Average Assumptions

The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the three months ended March 31, 2024 and 2023 were as follows:

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Expected term (in years)

 

 

5.79

 

 

 

5.82

 

Volatility

 

 

65

%

 

 

62

%

Risk-free interest rate

 

 

4.13

%

 

 

4.14

%

Dividend yield

 

 

0.00

%

 

 

0.00

%

Employee Stock Option  
Summary of Equity-Based Compensation Expense

Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the three months ended March 31, 2024 and 2023 is as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

6,083

 

 

$

4,729

 

General and administrative

 

 

5,885

 

 

 

4,656

 

Total equity-based compensation

 

$

11,968

 

 

$

9,385

 

 

Summary of Restricted Stock Activity

The Company has granted shares of restricted stock units with service-based and performance-based vesting conditions. A summary of restricted stock activity during the three months ended March 31, 2024 is as follows:

 

 

 

Number of
Units
Outstanding

 

 

Grant Date
Fair Value
per Share

 

Unvested at December 31, 2023

 

 

593,140

 

 

$

25.36

 

Granted

 

 

231,834

 

 

 

43.31

 

Vested

 

 

(83,209

)

 

 

33.08

 

Forfeited

 

 

(16,327

)

 

 

21.93

 

Unvested at March 31, 2024

 

 

725,438

 

 

$

30.29